Multiple local therapeutics based on nano-hydrogel composites in breast cancer treatment
Source abstract
Abstract
The locoregional recurrence of breast cancer after tumor resection represents several clinical challenges, and conventional post-surgical adjuvant therapeutics always bring about significant systemic side effects. Thus, the local therapy strategy has received considerable interest in breast cancer treatment, and hydrogels can function as ideal platforms due to their remarkable properties such as good biocompatibility, biodegradability, flexibility, and multifunctionality. The nano-hydrogel composites can further incorporate the advantages of nanomaterials into the hydrogel system, to fabricate hierarchical structures for stimulating controlled multi-stage release of different therapeutic agents and improving the synergistic effects of combination therapy. In this review, the problems of clinical treatments of breast cancer and properties of hydrogels in current biomedical applications are briefly overviewed. The focus is on recent advances in local therapy based on nano-hydrogel composites for both monotherapy (chemotherapy, photothermal and photodynamic therapy) and combination therapy (dual chemotherapy, photothermal chemotherapy, photothermal immunotherapy, radio-chemotherapy). Moreover, the challenges and perspectives in the development of advanced nano-hydrogel systems are also discussed.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Graphene and Nanomaterials Applications · Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Basic Medicine
Tongji Medical College
Huazhong University of Science and Technology
Wuhan
P. R. China
School of Pharmacy
Funding
National Natural Science Foundation of China · Huazhong University of Science and Technology · Fundamental Research Funds for the Central Universities
References (100+)
Show source-provided references
1. Jemal · Ca-Cancer J. Clin. · 2011 · 61 · 6910.3322/caac.20107 ↗
2. Wockel · Ann. Oncol. · 2014 · 25 · 62810.1093/annonc/mdt584 ↗
3. Aebi · Lancet Oncol. · 2014 · 15 · 15610.1016/S1470-2045(13)70589-8 ↗
4. Sepantafar · Trends Biotechnol. · 2017 · 35 · 107410.1016/j.tibtech.2017.06.015 ↗
5. Liu · Adv. Mater. · 2019 · 31 · 190204210.1002/adma.201902042 ↗
6. Han · iScience · 2020 · 23 · 10184510.1016/j.isci.2020.101845 ↗
7. Buwalda · J. Controlled Release · 2014 · 190 · 25410.1016/j.jconrel.2014.03.052 ↗
8. Luo · Carbohydr. Polym. · 2020 · 236 · 11606710.1016/j.carbpol.2020.116067 ↗
9. Li · Adv. Mater. · 2019 · 31 · 180733310.1002/adma.201807333 ↗
10. Zhao · Biomaterials · 2017 · 122 · 3410.1016/j.biomaterials.2017.01.011 ↗
11. Zhang · J. Colloid Interface Sci. · 2020 · 577 · 38810.1016/j.jcis.2020.05.087 ↗
12. Tamesue · ACS Appl. Mater. Interfaces · 2018 · 10 · 2738110.1021/acsami.8b10001 ↗
13. Liu · Small · 2017 · 13 · 170181510.1002/smll.201701815 ↗
14. Conde · Adv. Healthcare Mater. · 2016 · 5 · 231210.1002/adhm.201600414 ↗
15. Kearney · Nat. Mater. · 2013 · 12 · 100410.1038/nmat3758 ↗
16. Covas Moschovas · Eur. Urol. · 2020 · 78 · 87510.1016/j.eururo.2020.05.041 ↗
17. Jung · Breast Cancer Res. Treat. · 2020 · 183 · 37310.1007/s10549-020-05779-z ↗
18. Maluta · Breast Care · 2015 · 10 · 40810.1159/000440792 ↗
19. Seib · Adv. Funct. Mater. · 2013 · 23 · 5810.1002/adfm.201201238 ↗
20. Norouzi · Drug Discovery Today · 2016 · 21 · 183510.1016/j.drudis.2016.07.006 ↗
21. Harbeck · Lancet · 2017 · 389 · 113410.1016/S0140-6736(16)31891-8 ↗
22. Buzdar · Lancet Oncol. · 2013 · 14 · 131710.1016/S1470-2045(13)70502-3 ↗
23. Malhotra · Clin. Breast Cancer · 2004 · 5 · 37710.3816/CBC.2004.n.045 ↗
24. Sara · Ther. Adv. Med. Oncol. · 2018 · 10 · 110.1177/1758835918780140 ↗
25. Yang · Int. J. Mol. Sci. · 2017 · 18 · 173310.3390/ijms18081733 ↗
26. da Costa · Br. J. Pharmacol. · 2020 · 177 · 312710.1111/bph.15086 ↗
27. Ho · Crit. Rev. Oncol. Hematol. · 2016 · 102 · 3710.1016/j.critrevonc.2016.03.014 ↗
28. Yang · Biomater. Sci. · 2015 · 3 · 103510.1039/C4BM00369A ↗
29. Huo · ACS Nano · 2017 · 11 · 1015910.1021/acsnano.7b04737 ↗
30. Kim · Breast Cancer Res. Treat. · 2011 · 130 · 49910.1007/s10549-011-1736-3 ↗
31. Whaley · Int. J. Radiat. Oncol. · 2011 · 81 · S20710.1016/j.ijrobp.2011.06.378 ↗
32. Zhou · Asian Pac. J. Cancer Prev. · 2012 · 13 · 113110.7314/APJCP.2012.13.4.1131 ↗
33. Wang · Part. Part. Syst. Charact. · 2020 · 37 · 190042110.1002/ppsc.201900421 ↗
34. Kauer-Dorner · Breast Care · 2018 · 13 · 15710.1159/000489638 ↗
35. West · Breast J. · 2005 · 11 · 11510.1111/j.1075-122X.2005.21548.x ↗
36. Taylor · Int. J. Radiat. Oncol. · 2015 · 93 · 84510.1016/j.ijrobp.2015.07.2292 ↗
37. Masoud · World J. Clin. Oncol. · 2017 · 8 · 12010.5306/wjco.v8.i2.120 ↗
38. Burstein · J. Clin. Oncol. · 2014 · 32 · 225510.1200/JCO.2013.54.2258 ↗
39. Howell · Lancet · 2005 · 365 · 6010.1016/S0140-6736(05)74803-0 ↗
40. Glassman · Anticancer Res. · 2017 · 37 · 5329
41. Tryfonidis · Cancer Treat. Rev. · 2016 · 50 · 6810.1016/j.ctrv.2016.08.008 ↗
42. Robertson · Cancer · 2003 · 98 · 22910.1002/cncr.11468 ↗
43. Rosales · Nat. Rev. Mater. · 2016 · 1 · 1501210.1038/natrevmats.2015.12 ↗
44. Park · Nat. Commun. · 2014 · 5 · 407510.1038/ncomms5075 ↗
45. Park · Annu. Rev. Biomed. Eng. · 2017 · 19 · 10910.1146/annurev-bioeng-071516-044619 ↗
46. Wieringa · Adv. Healthcare Mater. · 2018 · 7 · e170116410.1002/adhm.201701164 ↗
47. Caliari · Nat. Methods · 2016 · 13 · 40510.1038/nmeth.3839 ↗
48. Zhang · Science · 2017 · 356 · eaaf362710.1126/science.aaf3627 ↗
49. Yuk · Chem. Soc. Rev. · 2019 · 48 · 164210.1039/C8CS00595H ↗
50. Yang · Adv. Sci. · 2020 · 7 · 190371810.1002/advs.201903718 ↗
51. Loessner · Adv. Drug Delivery Rev. · 2014 · 79–80 · 19310.1016/j.addr.2014.06.001 ↗
52. Taylor · Adv. Mater. · 2016 · 28 · 906010.1002/adma.201601613 ↗
53. Kleinman · Appl. Biol. Chem. · 2018 · 61 · 70310.1007/s13765-018-0400-6 ↗
54. Leitinger · Matrix Biol. · 2007 · 26 · 14610.1016/j.matbio.2006.10.007 ↗
55. Kadler · J. Cell Sci. · 2007 · 120 · 195510.1242/jcs.03453 ↗
56. Nguyen · Nat. Biomed. Eng. · 2017 · 1 · 009610.1038/s41551-017-0096 ↗
57. Boateng · J. Pharm. Sci. · 2015 · 104 · 365310.1002/jps.24610 ↗
58. Dorishetty · Adv. Colloid Interface Sci. · 2020 · 281 · 10216310.1016/j.cis.2020.102163 ↗
59. Ukeba · EBioMedicine · 2020 · 53 · 10269810.1016/j.ebiom.2020.102698 ↗
60. Liu · Acta Biomater. · 2018 · 75 · 21310.1016/j.actbio.2018.06.003 ↗
61. Vanacker · Ann. Biomed. Eng. · 2017 · 45 · 163310.1007/s10439-017-1816-6 ↗
62. El Nokab · Carbohydr. Polym. · 2020 · 240 · 11627610.1016/j.carbpol.2020.116276 ↗
63. Holland · Adv. Healthcare Mater. · 2019 · 8 · 180046510.1002/adhm.201800465 ↗
64. Rockwood · Nat. Protoc. · 2011 · 6 · 161210.1038/nprot.2011.379 ↗
65. Cowman · Front. Immunol. · 2015 · 6 · 26110.3389/fimmu.2015.00261 ↗
66. Highley · Curr. Opin. Biotech. · 2016 · 40 · 3510.1016/j.copbio.2016.02.008 ↗
67. Narkhede · J. Biomed. Mater. Res. A · 2018 · 106 · 183210.1002/jbm.a.36379 ↗
68. Rodell · Biomacromolecules · 2013 · 14 · 412510.1021/bm401280z ↗
69. Khetan · Nat. Mater. · 2013 · 12 · 45810.1038/nmat3586 ↗
70. Tzircotis · J. Cell Sci. · 2005 · 118 · 511910.1242/jcs.02629 ↗
71. Klotz · Trends Biotechnol. · 2016 · 34 · 39410.1016/j.tibtech.2016.01.002 ↗
72. Yao · ACS Omega · 2019 · 4 · 833410.1021/acsomega.9b00878 ↗
73. Xin · Adv. Healthcare Mater. · 2018 · 7 · 180016010.1002/adhm.201800160 ↗
74. Ozcelik · Acta Biomater. · 2013 · 9 · 659410.1016/j.actbio.2013.01.020 ↗
75. Zhang · Adv. Healthcare Mater. · 2015 · 4 · 226010.1002/adhm.201500406 ↗
76. Sridhar · Adv. Healthcare Mater. · 2015 · 4 · 70210.1002/adhm.201400695 ↗
77. Keskar · Tissue Eng., Part A · 2009 · 15 · 169510.1089/ten.tea.2008.0238 ↗
78. Akalin · Int. J. Biol. Macromol. · 2020 · 157 · 41410.1016/j.ijbiomac.2020.04.144 ↗
79. Colilla · Expert Opin. Ther. Pat. · 2008 · 18 · 63910.1517/13543776.18.6.639 ↗
80. Oyen · Int. Mater. Rev. · 2014 · 59 · 4410.1179/1743280413Y.0000000022 ↗
81. Wang · Macromol. Biosci. · 2020 · 20 · 200008210.1002/mabi.202000082 ↗
82. Stammen · Biomaterials · 2001 · 22 · 79910.1016/S0142-9612(00)00242-8 ↗
83. Ghorbel · Compos. Part A Appl. Sci. Manuf. · 2019 · 124 · 10546510.1016/j.compositesa.2019.05.033 ↗
84. Han · Proc. Natl. Acad. Sci. U. S. A. · 2016 · 113 · 1120810.1073/pnas.1610347113 ↗
85. Akbari · Adv. Funct. Mater. · 2014 · 24 · 406010.1002/adfm.201303655 ↗
86. Li · Chem. Soc. Rev. · 2012 · 41 · 219310.1039/C1CS15203C ↗
87. Zhao · Nanomaterials · 2015 · 5 · 205410.3390/nano5042054 ↗
88. Zhang · J. Mater. Chem. B · 2013 · 1 · 466710.1039/c3tb20597e ↗
89. Shi · Nano Lett. · 2010 · 10 · 322310.1021/nl102184c ↗
90. Sethi · Nanoscale · 2014 · 6 · 232110.1039/C3NR05961H ↗
91. Creixell · Nano Today · 2012 · 7 · 36710.1016/j.nantod.2012.06.013 ↗
92. Meng · ACS Nano · 2013 · 7 · 99410.1021/nn3044066 ↗
93. Guo · Drug Delivery · 2012 · 19 · 18810.3109/10717544.2012.690002 ↗
94. Lin · Nanoscale · 2016 · 8 · 1878210.1039/C6NR05498F ↗
95. Wu · Chin. Chem. Lett. · 2018 · 29 · 181910.1016/j.cclet.2018.10.004 ↗
96. Cao · Artif. Cells Nanomed. Biotechnol. · 2019 · 47 · 18110.1080/21691401.2018.1548470 ↗
97. Cacicedo · Colloids Surf. B · 2018 · 170 · 59610.1016/j.colsurfb.2018.06.056 ↗
98. Cacicedo · Colloids Surf. B · 2016 · 140 · 42110.1016/j.colsurfb.2016.01.007 ↗
99. Liu · ACS Appl. Mater. Interfaces · 2019 · 11 · 1970010.1021/acsami.9b01987 ↗
100. Yang · Int. J. Nanomed. · 2017 · 12 · 19710.2147/IJN.S121249 ↗